**This article has been corrected:** Due to errors during processing, [Figure 5D](#F1){ref-type="fig"} contains an incorrect image of H675Q MIA PaCa2. In addition, in [Figure 7B](#F2){ref-type="fig"}, the images of ASPH MIA PaCa2 treated with or without MO-I-1100 were also incorrect. In panel 7D, the image of Vector MIA PaCa2 (upper left) was incorrect as well. The corrected figures 5 and 7 are shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
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![The β-hydroxylase activity of ASPH is required for its transforming activity.\
MIA PaCa2 cells were stably transfected with empty vector (EV), "wild type" (WT)-ASPH, or H^675^Q-ASPH mutant and the levels of expression were confirmed by Western blot. There is low-level endogenous ASPH in MIA PaCa2 cells as shown here and in Fig. 1. Effects of EV, WT-ASPH and H^675^Q-ASPH on (**A**) cell proliferation, (**B**) migration, (**C**) invasion, and (**D**) colony formation are significantly different. (**E** and **F**) represents a Western blot demonstrating WT-ASPH induced activation of Notch signaling as determined by increased levels of Notch1 ICN, JAG2, as well as increased expression of downstream responsive genes HES1, HEY1, EpCAM, CD44, c-Myc, MMP2/9, cyclin D3 and PCNA. In contrast, the mutant H^675^Q ASPH construct shows significantly reduced activated Notch1 ICN, JAG2, as well as HES1, HEY1, EpCAM, CD44, c-Myc, MMP2/9, cyclin D3 and PCNA. The results suggest that the β-hydroxylase activity of ASPH is essential for Notch signaling activation. ^\*^ *p*\<0.05; ^\*\*^ *p*\<0.01; ^\*\*\*^ *p*\<0.001.](oncotarget-10-6644-g001){#F1}

![Effect of SMI MO-I-1100 on the PC phenotype induced by exogenous or endogenous high-level of WT-ASPH expression.\
MIA PaCa2 cells stably transfected with empty vector or the "wild type" ASPH construct via lentiviral transfection depicted in Fig. 2. The inhibitory effects of MO-I-1100 on (**A**) proliferation, (**B**) migration, (**C**) invasion, and (d) colony formation of MIA PaCa2 cells were observed. There is a significant reduction in the expression of Notch1 ICN, JAG2, as well as downstream responsive genes HES1, HEY1, EpCAM, CD44, c-Myc, MMP2/9, cyclin D3 and PCNA induced by MO-I-1100 compared to the DMSO treatment (**E** and **F**). ^\*^ *p*\<0.05; ^\*\*^ *p*\<0.01; ^\*\*\*^ *p*\<0.001.](oncotarget-10-6644-g002){#F2}
